Phase II Study of Reuse of Oxaliplatin Hypersensitivity in Gastrointestinal Tumors
Condition(s):Gastrointestinal TumorsLast Updated:June 28, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Gastrointestinal TumorsLast Updated:June 28, 2023Not yet recruiting
Condition(s):Advanced Adult Primary Liver CancerLast Updated:September 23, 2015Unknown status
Condition(s):Cancer of the Head and Neck; Neoplasms, Head and NeckLast Updated:December 10, 2013Terminated
Condition(s):Esophageal CancerLast Updated:November 18, 2019Completed
Condition(s):Advanced Colorectal CancerLast Updated:May 20, 2022Not yet recruiting
Condition(s):Rectal Cancer; ConsolidationLast Updated:March 7, 2024Recruiting
Condition(s):Colorectal Cancer; Appendiceal Cancer; Peritoneal CarcinomaLast Updated:September 27, 2021Terminated
Condition(s):Pancreatic AdenocarcinomaLast Updated:August 2, 2021Unknown status
Condition(s):Phase I: To Determine the Maximum Tolerated Dose (MTD); Phase II: To Assess the Pathologic CR Rate and Feasibility Following Neoadjuvant Chemoradiation Therapy With S1/OxaliplatinLast Updated:June 14, 2013Terminated
Condition(s):Stomach NeoplasmLast Updated:August 23, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.